Filed: 11/14/2024ACC: 0001420506-24-002562
📋 What this filing means
IKARIAN CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 121 equity positions with a total reported market value of $717.15M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
121
Positions
$717.15M
Total AUM (reported)
47.18M
Total Shares
Allocation by class
COM$510.22M71.1%
COM NEW$99.90M13.9%
S&P BIOTECH$49.40M6.9%
COM PAR $.01$11.30M1.6%
COM SHS$10.08M1.4%
SPONSORED ADR$8.33M1.2%
SPONSORED ADS$8.14M1.1%
Portfolio Concentration
Top 3$193.74M27.0%
4–10$151.33M21.1%
11–25$172.82M24.1%
Rest$199.26M27.8%
Top 3 weight
27.0%
Top 10 weight
48.1%
Voting Authority Distribution
Total shares with voting rights: 47.18M
Sole
Full voting authority
47.18M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole121
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings121
Rows:
VERTEX PHARMACEUTICALS INC
SOLEShares200K
TypeSH
Market value$93.02M
12.97%
Sole
200K
Shared
0.00
None
0.00
AMGEN INC
SOLEShares159.30K
TypeSH
Market value$51.33M
7.16%
Sole
159.30K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares500K
TypeSH
Market value$49.40M
6.89%
Sole
500K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares1.03M
TypeSH
Market value$33.89M
4.73%
Sole
1.03M
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares754.30K
TypeSH
Market value$25.27M
3.52%
Sole
754.30K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares426.91K
TypeSH
Market value$21.82M
3.04%
Sole
426.91K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares611K
TypeSH
Market value$20.77M
2.90%
Sole
611K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares331.44K
TypeSH
Market value$16.73M
2.33%
Sole
331.44K
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares365.20K
TypeSH
Market value$16.59M
2.31%
Sole
365.20K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares325.60K
TypeSH
Market value$16.27M
2.27%
Sole
325.60K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares699.98K
TypeSH
Market value$15.92M
2.22%
Sole
699.98K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares500K
TypeSH
Market value$14.26M
1.99%
Sole
500K
Shared
0.00
None
0.00
CAPRICOR THERAPEUTICS INC
SOLEShares900K
TypeSH
Market value$13.69M
1.91%
Sole
900K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares857.70K
TypeSH
Market value$13.11M
1.83%
Sole
857.70K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares625.62K
TypeSH
Market value$12.91M
1.80%
Sole
625.62K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares499.57K
TypeSH
Market value$12.76M
1.78%
Sole
499.57K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares222.45K
TypeSH
Market value$11.75M
1.64%
Sole
222.45K
Shared
0.00
None
0.00
INSMED INC
SOLEShares154.84K
TypeSH
Market value$11.30M
1.58%
Sole
154.84K
Shared
0.00
None
0.00
NEUMORA THERAPEUTICS INC.
SOLEShares800K
TypeSH
Market value$10.57M
1.47%
Sole
800K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares350K
TypeSH
Market value$10.09M
1.41%
Sole
350K
Shared
0.00
None
0.00
ALTO NEUROSCIENCE INC
SOLEShares881K
TypeSH
Market value$10.08M
1.41%
Sole
881K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares179K
TypeSH
Market value$9.94M
1.39%
Sole
179K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares970.36K
TypeSH
Market value$9.22M
1.29%
Sole
970.36K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares302.25K
TypeSH
Market value$8.89M
1.24%
Sole
302.25K
Shared
0.00
None
0.00
BEIGENE LTD
SOLEShares117.97K
TypeSH
Market value$8.33M
1.16%
Sole
117.97K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VERTEX PHARMACEUTICALS INCSOLE | COM | 200K | SH | $93.02M 12.97% | 200K | 0.00 | 0.00 |
AMGEN INCSOLE | COM | 159.30K | SH | $51.33M 7.16% | 159.30K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 500K | SH | $49.40M 6.89% | 500K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 1.03M | SH | $33.89M 4.73% | 1.03M | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 754.30K | SH | $25.27M 3.52% | 754.30K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 426.91K | SH | $21.82M 3.04% | 426.91K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 611K | SH | $20.77M 2.90% | 611K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 331.44K | SH | $16.73M 2.33% | 331.44K | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 365.20K | SH | $16.59M 2.31% | 365.20K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 325.60K | SH | $16.27M 2.27% | 325.60K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 699.98K | SH | $15.92M 2.22% | 699.98K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 500K | SH | $14.26M 1.99% | 500K | 0.00 | 0.00 |
CAPRICOR THERAPEUTICS INCSOLE | COM NEW | 900K | SH | $13.69M 1.91% | 900K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 857.70K | SH | $13.11M 1.83% | 857.70K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 625.62K | SH | $12.91M 1.80% | 625.62K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 499.57K | SH | $12.76M 1.78% | 499.57K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 222.45K | SH | $11.75M 1.64% | 222.45K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 154.84K | SH | $11.30M 1.58% | 154.84K | 0.00 | 0.00 |
NEUMORA THERAPEUTICS INC.SOLE | COM | 800K | SH | $10.57M 1.47% | 800K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 350K | SH | $10.09M 1.41% | 350K | 0.00 | 0.00 |
ALTO NEUROSCIENCE INCSOLE | COM SHS | 881K | SH | $10.08M 1.41% | 881K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 179K | SH | $9.94M 1.39% | 179K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 970.36K | SH | $9.22M 1.29% | 970.36K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 302.25K | SH | $8.89M 1.24% | 302.25K | 0.00 | 0.00 |
BEIGENE LTDSOLE | SPONSORED ADR | 117.97K | SH | $8.33M 1.16% | 117.97K | 0.00 | 0.00 |
Page 1 of 5
…